Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 genomes project data

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Indolfi, Giuseppe ^a   Mangone, Giusi ^a   Bartolini, Elisa ^a   Nebbia, Gabriella ^b   Calvo, Pier Luigi ^c   Moriondo, Maria ^a   Tovo, Pier Angelo ^c   De Martino, Maurizio ^d   Azzari, Chiara ^a,d   Resti, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 28B;

ALLELE; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HUMAN; HUMAN GENOME PROJECT; IFNL3 GENE; ITALIAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERINATAL INFECTION; PERSISTENT VIRUS INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; DATABASES, GENETIC; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HEPATITIS C; HUMANS; INTERLEUKINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898670631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085899     Document Type: Article

References (22)

1. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
2. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009). Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
3. Urban T, Charlton MR, Goldstein DB (2012) Introduction to the genetics and biology of interleukin-28B. Hepatology 56: 361-366.
4. Yan KK, Guirgis M, Dinh T, George J, Dev A, et al. (2008) Treatment responses in Asians and Caucasians with chronic hepatitis C infection. World J Gastroenterol 14: 3416-3420.
5. Muir AJ, Bornstein JD, Killenberg PG; Atlantic Coast Hepatitis Treatment Group (2004) Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 350: 2265-2271. (Pubitemid 38669209)
6. Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, et al. (2008) Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. Clin Infect Dis 47: 1260-1269.
7. Ruiz-Extremera A, Muñoz-Gámez JA, Salmerón-Ruiz MA, de Rueda PM, Quiles-Pérez R, et al. (2011) Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology 53: 1830-1838.
8. Indolfi G, Sambrotta M, Moriondo M, Azzari C, Resti M (2011) Genetic variation in interleukin-28B locus is associated with spontaneous clearance of HCV in children with non-1 viral genotype infection. Hepatology 54: 1490-1491.
9. Bortolotti F, Verucchi G, Cammà C, Cabibbo G, Zancan L, et al. (2008) Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 134: 1900-1907. (Pubitemid 351783258)
10. Afdhal NH (2004) The natural history of hepatitis C. Semin Liver Dis 24: 3-8.
11. Prendergast AJ, Klenerman P, Goulder PJ (2012) The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 12: 636-648.
12. Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
13. Indolfi G, Azzari C, Resti M (2013) Perinatal Transmission of Hepatitis C Virus. J Pediatr 163: 1549-1552.
14. Indolfi G, Resti M (2009) Perinatal transmission of hepatitis C virus infection. J Med Virol 81: 836-843.
15. Resti M, Jara P, Hierro L, Azzari C, Giacchino R, et al. (2003) Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 70:373-377. (Pubitemid 36638049)
16. Indolfi G, Azzari C, Moriondo M, Lippi F, de Martino M, et al. (2006) Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission. J Med Virol 78: 911-914. (Pubitemid 43856698)
17. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, et al. (2008) Genes mirror geography within Europe. Nature 456: 98-101.
18. Stathias V, Sotiris GR, Karagiannidis I, Bourikas G, Martinis G, et al. (2012) Exploring genomic structure differences and similarities between the Greek and European HapMap populations: implications for association studies. Ann Hum Genet 76: 472-483.
19. European Paediatric Hepatitis C Virus Network. (2005) Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 41: 45-51.
20. Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, et al. (2011) Interferon-lambda serum levels in hepatitis C. J Hepatol 54: 859-865.
21. Naggie S, Osinusi A, Katsounas A, Lempicki R, Herrmann E, et al. (2012) Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response. Hepatology 56: 444-454.
22. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, et al. (2009) Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 183: 7150-7160.